US20020137890A1
(en)
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US7057017B2
(en)
|
1997-04-16 |
2006-06-06 |
Millennium Pharmaceuticals, Inc. |
Human dickkopf-related protein and nucleic acid molecules and uses therefor
|
US20030069403A1
(en)
|
1997-06-16 |
2003-04-10 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US7446181B2
(en)
|
1998-01-15 |
2008-11-04 |
Millennium Pharmaceuticals, Inc. |
Antibodies that bind human Dickkopf-1 proteins
|
US20030149531A1
(en)
|
2000-12-06 |
2003-08-07 |
Hubert Rene S. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
US6833438B1
(en)
|
1999-06-01 |
2004-12-21 |
Agensys, Inc. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
JP4855577B2
(ja)
|
1998-06-01 |
2012-01-18 |
アジェンシス,インコーポレイテッド |
ヒト癌で発現される新規蛇行性膜貫通抗原およびその使用
|
US20020172678A1
(en)
|
2000-06-23 |
2002-11-21 |
Napoleone Ferrara |
EG-VEGF nucleic acids and polypeptides and methods of use
|
US7264801B2
(en)
|
1998-08-11 |
2007-09-04 |
Genentech, Inc. |
EG-VEGF nucleic acids and polypeptides and method of use
|
US20030003507A1
(en)
|
1999-06-02 |
2003-01-02 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
US6344541B1
(en)
|
1998-09-25 |
2002-02-05 |
Amgen Inc. |
DKR polypeptides
|
WO2000042165A2
(fr)
|
1999-01-15 |
2000-07-20 |
Human Genome Sciences, Inc. |
Proteine specifique de la moelle osseuse
|
US7034132B2
(en)
|
2001-06-04 |
2006-04-25 |
Anderson David W |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
AU3774300A
(en)
*
|
1999-06-02 |
2000-12-18 |
Genentech Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
WO2001014552A1
(fr)
*
|
1999-08-19 |
2001-03-01 |
Kurokawa, Kiyoshi |
Proteine meg-1
|
US7790861B2
(en)
*
|
1999-09-24 |
2010-09-07 |
Philadelphia Health And Education Corporation |
Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms
|
US20020042062A1
(en)
|
1999-09-24 |
2002-04-11 |
Mark Stearns |
Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms
|
JP2003520031A
(ja)
*
|
1999-11-12 |
2003-07-02 |
ヒューマン ジノーム サイエンシーズ, インコーポレイテッド |
28個のヒト分泌タンパク質
|
CA2395416A1
(fr)
|
1999-12-23 |
2001-06-28 |
Millennium Pharmaceuticals, Inc. |
Recepteur p2y12
|
AU781508B2
(en)
|
2000-02-11 |
2005-05-26 |
Glycozym Aps |
UDP-galactose: beta-D-galactose-R 4-alpha-D-galactosyltransferase, alpha4Gal-T1
|
JP4342069B2
(ja)
*
|
2000-02-14 |
2009-10-14 |
生化学工業株式会社 |
α1,4−ガラクトース転移酵素およびそれをコードするDNA
|
AU6802801A
(en)
*
|
2000-03-01 |
2001-09-24 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US20020065223A1
(en)
*
|
2000-06-16 |
2002-05-30 |
Glucksmann Maria Alexandra |
33358, a novel human ankyrin family member and uses thereof
|
EP1698697A3
(fr)
*
|
2000-03-24 |
2006-09-13 |
Takeda Pharmaceutical Company Limited |
Protéine contenant SSD, son procédé de préparation et son utilisation
|
JP2003530124A
(ja)
*
|
2000-04-05 |
2003-10-14 |
麒麟麦酒株式会社 |
新規幹細胞成長因子様ポリペプチドおよびポリヌクレオチドに関する方法および物質
|
EP1287124A2
(fr)
*
|
2000-04-18 |
2003-03-05 |
Bayer Aktiengesellschaft |
Regulation de la serine protease semblable a l'epithine humaine
|
EP1280917A2
(fr)
*
|
2000-04-26 |
2003-02-05 |
Millennium Pharmaceuticals, Inc. |
21657, deshydrogenase humaine a chaine courte et ses utilisations
|
US20030092035A1
(en)
|
2000-05-04 |
2003-05-15 |
Anderson David J. |
Pain signaling molecules
|
US7510845B2
(en)
|
2000-05-04 |
2009-03-31 |
California Institute Of Technology |
Assay employing G protein-coupled receptor expressed in dorsal root ganglia
|
WO2001085935A2
(fr)
*
|
2000-05-09 |
2001-11-15 |
Bayer Aktiengesellschaft |
Recepteur couple a une proteine g du type du gene 6 de differenciation endotheliale
|
EP1311688A2
(fr)
*
|
2000-05-26 |
2003-05-21 |
Millennium Pharmaceuticals, Inc. |
Lipase humaine 50250 et utilisations
|
CA2414015A1
(fr)
*
|
2000-06-21 |
2001-12-27 |
Incyte Genomics, Inc. |
Recepteurs
|
WO2002000861A2
(fr)
*
|
2000-06-26 |
2002-01-03 |
Millennium Pharmaceuticals, Inc. |
46619, une nouvelle synthase beta-cetoacyle et utilisations de cette derniere
|
AU2001281933A1
(en)
*
|
2000-06-30 |
2002-01-14 |
Ingenium Pharmaceuticals Ag |
Human g protein-coupled receptor igpcr17, and uses therof
|
AU2001281974A1
(en)
*
|
2000-07-13 |
2002-01-30 |
Novartis Ag |
Disease-associated gene
|
AU2001278488A1
(en)
*
|
2000-07-25 |
2002-02-05 |
Bayer Aktiengesellschaft |
Regulation of human matriptase-like serine protease
|
EP1307557A2
(fr)
|
2000-08-02 |
2003-05-07 |
The Johns Hopkins University |
Profils d'expression de cellules endotheliales
|
EP1315431A1
(fr)
*
|
2000-08-02 |
2003-06-04 |
Millennium Pharmaceuticals, Inc. |
Membre de la famille du facteur de liberation du gtp humain (15368) et ses utilisations
|
PT1313762E
(pt)
*
|
2000-08-04 |
2006-11-30 |
Ludwig Inst Cancer Res |
Gene supressor
|
EP1688496A3
(fr)
*
|
2000-08-14 |
2006-08-16 |
Actimis Pharmaceuticals, Inc., |
Régulation du récepteur couple aux protéines g du type récepteur p2y1
|
DE60116515T2
(de)
*
|
2000-08-14 |
2006-09-07 |
Actimis Pharmaceuticals, Inc., La Jolla |
Regulierung des menschlichen p2y1-ähnlichen g-protein gekoppelten rezeptors
|
AU2001284902A1
(en)
*
|
2000-08-15 |
2002-02-25 |
Zymogenetics Inc. |
Human adenosine deaminase
|
WO2002016586A2
(fr)
*
|
2000-08-21 |
2002-02-28 |
Bristol-Myers Squibb Company |
Nouvel homologue d'adenosine deaminase
|
US20030166300A1
(en)
*
|
2000-08-30 |
2003-09-04 |
Tang Y. Tom |
Growth-related inflammatory and immune response protein
|
US20030224396A1
(en)
*
|
2000-08-30 |
2003-12-04 |
Yonghong Xiao |
Regulation of human aminotransferase-like enzyme
|
US20040072185A1
(en)
*
|
2000-09-15 |
2004-04-15 |
Patrizia Paterlini-Brechot |
Cellular genes involved in oncogenesis, products of said genes and their diagnostic and therapeutic uses
|
US7754435B2
(en)
*
|
2000-09-21 |
2010-07-13 |
Philadelphia Health And Education Corporation |
Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms
|
JP2004524819A
(ja)
*
|
2000-10-04 |
2004-08-19 |
キュラジェン コーポレイション |
新規なタンパク質およびこれをコードする核酸ならびにこれらのタンパク質に対する抗体
|
AU2002220613A1
(en)
*
|
2000-10-11 |
2002-04-22 |
Bayer Aktiengesellschaft |
Regulation of human cyclophilin-type peptidyl-prolyl cis-trans isomerase
|
AU2001297794A1
(en)
|
2000-10-19 |
2002-12-03 |
Millenium Pharmaceuticals, Inc. |
Methods and compositions of human proteins and uses thereof.
|
AU2002230778A1
(en)
|
2000-11-03 |
2002-05-15 |
The Regents Of The University Of California |
Prokineticin polypeptides, related compositions and methods
|
US20030009017A1
(en)
*
|
2000-11-08 |
2003-01-09 |
Leiby Kevin R. |
38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof
|
AU2002229011A1
(en)
*
|
2000-11-09 |
2002-05-21 |
Glaxo Group Limited |
Deaminase catalyzing the removal of the cyclopropyl moiety from abacavir-mp
|
US7129057B2
(en)
*
|
2000-11-09 |
2006-10-31 |
University Of Virginia Patent Foundation |
Human testis specific serine/threonine kinase 3
|
US7312086B2
(en)
|
2000-12-07 |
2007-12-25 |
Bristol-Myers Squibb Company |
Methods of diagnosing colon adenocarcinoma using the human g-protein coupled receptor hgprbmy23
|
CA2433027A1
(fr)
*
|
2000-12-21 |
2002-06-27 |
Incyte Genomics, Inc. |
Proteines associees a un acide nucleique
|
US7892730B2
(en)
*
|
2000-12-22 |
2011-02-22 |
Sagres Discovery, Inc. |
Compositions and methods for cancer
|
US20030148920A1
(en)
*
|
2000-12-27 |
2003-08-07 |
Steven Rosen |
Sulfatases and methods of use thereof
|
WO2002053719A2
(fr)
*
|
2001-01-04 |
2002-07-11 |
Incyte Genomics, Inc. |
Proteines associees au cytosquelette
|
JP2005500818A
(ja)
*
|
2001-01-05 |
2005-01-13 |
インサイト・ゲノミックス・インコーポレイテッド |
疾患検出および治療用分子
|
US6319679B1
(en)
*
|
2001-01-26 |
2001-11-20 |
Board Of Regents, The University Of Texas System |
PAS kinase
|
US20020115136A1
(en)
*
|
2001-02-07 |
2002-08-22 |
Gennady Merkulov |
Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
|
AU2002247716A1
(en)
*
|
2001-02-14 |
2002-08-28 |
Axaron Bioscience Ag |
Proteins 7b6 and 11b4 and dna sequences encoding the same
|
EP1521824A2
(fr)
*
|
2001-03-16 |
2005-04-13 |
Incyte Genomics, Inc. |
Acide nucleique et proteines associees
|
US20030044813A1
(en)
*
|
2001-03-30 |
2003-03-06 |
Old Lloyd J. |
Cancer-testis antigens
|
US20020146795A1
(en)
*
|
2001-04-02 |
2002-10-10 |
Shiaoping Zhu |
Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof
|
CA2443123A1
(fr)
|
2001-04-10 |
2002-10-24 |
Agensys, Inc. |
Acides nucleiques et proteines correspondantes utiles pour la detection et le traitement de divers cancers
|
US7927597B2
(en)
*
|
2001-04-10 |
2011-04-19 |
Agensys, Inc. |
Methods to inhibit cell growth
|
US6962811B2
(en)
|
2001-05-09 |
2005-11-08 |
Millennium Pharmaceuticals, Inc. |
14715, a human fringe family member nucleic acids and uses therefor
|
EP1403368B1
(fr)
|
2001-05-29 |
2010-09-01 |
Human Cell Systems, Inc. |
Transporteur de carnitine testiculaire et son gene
|
ATE483976T1
(de)
|
2001-06-05 |
2010-10-15 |
Exelixis Inc |
Gfats als modifikatoren des p53-wegs und verwendungsverfahren
|
EP1409549A4
(fr)
*
|
2001-06-20 |
2007-10-24 |
Genentech Inc |
Compositions et procedes destines au diagnostic et au traitement de tumeurs
|
WO2003000874A2
(fr)
*
|
2001-06-25 |
2003-01-03 |
Bayer Aktiengesellschaft |
Regulation de la proteine kinase serine/threonine humaine nek3
|
WO2003022995A2
(fr)
|
2001-09-06 |
2003-03-20 |
Agensys, Inc. |
Acide nucleique et proteine correspondante designes par steap-1 utiles dans le traitement et la detection du cancer
|
US7494646B2
(en)
|
2001-09-06 |
2009-02-24 |
Agensys, Inc. |
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
|
ATE346305T1
(de)
*
|
2001-09-24 |
2006-12-15 |
Gruenenthal Gmbh |
Screeningverfahren für verschiedene indikationen mit bnpi und/oder dnpi
|
US7265214B2
(en)
*
|
2001-10-19 |
2007-09-04 |
Rigel Pharmaceuticals, Inc. |
Germinal center kinase proteins, compositions and methods of use
|
EP1512007A4
(fr)
*
|
2001-10-29 |
2005-08-17 |
Millennium Pharm Inc |
32235, membre de la famille de l'aminotransferase humaine et ses utilisations
|
EP1439864A4
(fr)
*
|
2001-10-31 |
2004-12-22 |
Millennium Pharm Inc |
Procedes de traitement et de diagnostic de troubles de nature tumorigene et/ou angiogene recourant au 32616
|
EP1440169A4
(fr)
*
|
2001-10-31 |
2005-09-21 |
Millennium Pharm Inc |
Procedes et compositions pour le traitement et le diagnostic d'algies utilisant le 57749
|
DE60220621T2
(de)
|
2001-11-09 |
2008-03-06 |
Proteologics, Inc. |
Posh Nukleinsäure, Polypeptide und darauf bezogene Verfahren
|
AU2002360460A1
(en)
*
|
2001-12-03 |
2003-06-17 |
Nuvelo, Inc. |
Methods and materials relating to novel polypeptides and polynucleotides
|
EP1450852B1
(fr)
*
|
2001-12-04 |
2007-01-17 |
DeveloGen Aktiengesellschaft |
Acides nucleiques et peptides de ptp10d intervenant dans la regulation de l'homeostasie energetique
|
US20060051852A1
(en)
*
|
2001-12-12 |
2006-03-09 |
Smith Thomas M |
Apyrase polypeptides and nucleic acids encoding same
|
WO2003051917A2
(fr)
*
|
2001-12-18 |
2003-06-26 |
Endocube Sas |
Nouvelles proteines associees a la mort, et mecanismes d'action de thap1 et para4 dans la maitrise de l'apoptose
|
US7858297B2
(en)
*
|
2001-12-18 |
2010-12-28 |
Centre National De La Recherche Scientifique Cnrs |
Chemokine-binding protein and methods of use
|
EP1473365A1
(fr)
*
|
2002-02-04 |
2004-11-03 |
Takeda Chemical Industries, Ltd. |
Inhibiteurs d'angiogenese
|
GB0205112D0
(en)
*
|
2002-03-05 |
2002-04-17 |
Pantherix Ltd |
Enzyme
|
WO2003076072A1
(fr)
|
2002-03-11 |
2003-09-18 |
Japan Science And Technology Agency |
Catalyseur de zirconium chiral pratique
|
DE10212397A1
(de)
*
|
2002-03-20 |
2003-10-16 |
Universitaetsklinikum Freiburg |
Repressor der Skelettmuskeldifferenzierung, dafür kodierende Nucleinsäure und dessen Verwendung in Diagnostik und Therapie
|
US20050065082A1
(en)
*
|
2002-03-29 |
2005-03-24 |
Hirofumi Doi |
C-jun phosphorylation inhibitors
|
WO2003082342A1
(fr)
*
|
2002-04-01 |
2003-10-09 |
National Institute Of Advanced Industrial Science And Technology |
Utilisation du gene k1aa0172 pour le traitement et le diagnostic de maladies et decouverte de medicaments
|
US7622443B2
(en)
|
2002-04-26 |
2009-11-24 |
California Institute Of Technology |
Method for inhibiting pro-angiogenic activities of endothelial cells selectively at a site of neoangiogenesis in a mammal by administration of the extracellular domain of D1-1 polypeptides
|
US7538088B2
(en)
|
2002-04-26 |
2009-05-26 |
California Institute Of Technology |
Method for inhibiting angiogenesis by administration of the extracellular domain of D1-1 polypeptide
|
DE10222845A1
(de)
*
|
2002-05-23 |
2003-12-04 |
Dresden Arzneimittel |
Klonierung, Expression und Charakterisierung der Gesamtsequenz von Phosphodiesterase 8B
|
WO2004003165A2
(fr)
*
|
2002-06-28 |
2004-01-08 |
Imclone Systems Incorporated |
Nouvelles sequences polynucleotidiques et polypeptidiques et leurs utilisations
|
CA2493007A1
(fr)
*
|
2002-07-19 |
2004-01-29 |
Cellzome Ag |
Complexes proteiques de la proteine activatrice de la transcription de tip60
|
US7135556B2
(en)
|
2002-07-19 |
2006-11-14 |
Schering Corporation |
NPC1L1 (NPC3) and methods of use thereof
|
JP2004290170A
(ja)
*
|
2002-08-02 |
2004-10-21 |
Takeda Chem Ind Ltd |
疾患関連遺伝子の用途
|
TW200413725A
(en)
*
|
2002-09-30 |
2004-08-01 |
Oncotherapy Science Inc |
Method for diagnosing non-small cell lung cancers
|
US7056685B1
(en)
|
2002-11-05 |
2006-06-06 |
Amgen Inc. |
Receptor ligands and methods of modulating receptors
|
WO2004046342A2
(fr)
*
|
2002-11-20 |
2004-06-03 |
Biogen Idec Inc. |
Nouvelles cibles geniques et ligands se liant a ces cibles dans le traitement et le diagnostic de carcinomes
|
WO2004055050A2
(fr)
*
|
2002-12-10 |
2004-07-01 |
Endocube Sas |
Proteines thap tenant lieu de recepteurs nucleaires des chimiokines et leurs roles dans la regulation transcriptionnelle, la proliferation cellulaire et la differenciation cellulaire
|
JP4140951B2
(ja)
*
|
2002-12-18 |
2008-08-27 |
独立行政法人科学技術振興機構 |
転写制御因子zhx3
|
WO2004061108A1
(fr)
*
|
2002-12-29 |
2004-07-22 |
Toudai Tlo, Ltd. |
Recepteur de l'adiponectine et gene codant pour ce recepteur
|
EP1585815A4
(fr)
*
|
2003-01-21 |
2006-02-22 |
Bristol Myers Squibb Co |
Polynucleotide codant une nouvelle co-enzyme d'acyle a, monoacylglycerol acyltransferase-2 (mgat2), et utilisations de ceux-ci
|
CN1747744B
(zh)
*
|
2003-02-03 |
2011-07-27 |
独立行政法人科学技术振兴机构 |
使用otx2基因再生和新生视网膜感光细胞
|
WO2005051988A2
(fr)
*
|
2003-03-03 |
2005-06-09 |
Genentech, Inc. |
Compositions et procedes permettant de traiter un lupus erythemateux systemique
|
WO2004098515A2
(fr)
*
|
2003-04-30 |
2004-11-18 |
Agensys, Inc. |
Acides nucleiques et proteines correspondantes appelees 109p1d4 utiles dans le traitement et la detection du cancer
|
WO2004104218A1
(fr)
*
|
2003-05-23 |
2004-12-02 |
Bayer Healthcare Ag |
Agents diagnostiques et therapeutiques destines a des maladies associees a x-prolyl aminopeptidase 1 (xpnpep1)
|
WO2005023855A2
(fr)
*
|
2003-09-10 |
2005-03-17 |
Friedrich-Alexander-Uni- Versitatet Erlangen- Nuernberg |
Gene et proteine k203
|
WO2005030953A1
(fr)
*
|
2003-09-30 |
2005-04-07 |
Daiichi Pharmaceutical Co., Ltd. |
Gene de tetrahydrofolate synthase
|
WO2005059504A2
(fr)
*
|
2003-12-12 |
2005-06-30 |
Bayer Healthcare Ag |
Diagnostics et therapeutique destines au traitement de maladies associees au recepteur couple aux proteines g gpr34 (gpr34)
|
US7901893B2
(en)
|
2004-01-16 |
2011-03-08 |
Merck Sharp & Dohme Corp. |
NPC1L1 (NPC3) and methods of identifying ligands thereof
|
WO2005077091A2
(fr)
*
|
2004-02-10 |
2005-08-25 |
Trustees Of Dartmouth College |
Compositions de nicotinamide riboside kinase et procedes d'utilisation
|
US8010189B2
(en)
|
2004-02-20 |
2011-08-30 |
Brainsgate Ltd. |
SPG stimulation for treating complications of subarachnoid hemorrhage
|
US8055347B2
(en)
|
2005-08-19 |
2011-11-08 |
Brainsgate Ltd. |
Stimulation for treating brain events and other conditions
|
US9233245B2
(en)
|
2004-02-20 |
2016-01-12 |
Brainsgate Ltd. |
SPG stimulation
|
EP1786833A4
(fr)
*
|
2004-03-19 |
2009-02-25 |
Univ Yale |
Detection, isolement et utilisations de la renalase (monoamine oxydase de type c)
|
ATE430763T1
(de)
*
|
2004-03-30 |
2009-05-15 |
Nsgene As |
Therapeutische verwendung des wachstumsfaktors nsg33
|
US20050222040A1
(en)
*
|
2004-04-05 |
2005-10-06 |
Blm Group, Inc. |
Vertebrate peptide modulators of lipid metabolism
|
DK1742966T3
(da)
|
2004-04-22 |
2014-02-03 |
Agensys Inc |
Antistoffer og molekyler afledt deraf som binder til STEAP-1 proteiner
|
US7709611B2
(en)
|
2004-08-04 |
2010-05-04 |
Amgen Inc. |
Antibodies to Dkk-1
|
WO2006069592A2
(fr)
*
|
2004-12-31 |
2006-07-06 |
Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg |
Methode permettant de diagnostiquer et/ou de predire la toxemie preeclamptique et/ou des troubles associes
|
FI20050011A
(fi)
*
|
2005-01-05 |
2006-07-06 |
Jurilab Ltd Oy |
Menetelmä ja testipakkaus tyypin 2 diabetes mellituksen riskin havaitsemiseksi
|
WO2006074914A2
(fr)
*
|
2005-01-13 |
2006-07-20 |
Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research |
Helicase d'arn humaine et ses utilisations therapeutiques
|
US7521195B1
(en)
|
2005-07-21 |
2009-04-21 |
Celera Corporation |
Lung disease targets and uses thereof
|
WO2007059357A1
(fr)
|
2005-11-21 |
2007-05-24 |
Yale University |
Procedes de regulation de la renalase (monoamine oxydase c)
|
WO2007060899A1
(fr)
*
|
2005-11-22 |
2007-05-31 |
National University Corporation Nagoya University |
Application d'une protéine se liant à l’actine à une maladie associée à la motilité cellulaire
|
US7910698B2
(en)
|
2006-02-24 |
2011-03-22 |
Schering Corporation |
NPC1L1 orthologues
|
AU2007308792B2
(en)
|
2006-10-27 |
2013-01-24 |
Genentech, Inc. |
Antibodies and immunoconjugates and uses therefor
|
EP2152292A4
(fr)
*
|
2007-05-02 |
2011-04-27 |
Snu R&Db Foundation |
Inhibiteur de l'angiogenèse comprenant de la météorine en tant que principe actif
|
PL3009148T3
(pl)
|
2007-07-02 |
2019-03-29 |
Oncomed Pharmaceuticals, Inc. |
Kompozycje oraz sposoby leczenia i diagnozowania nowotworu
|
EP2170374A2
(fr)
*
|
2007-07-03 |
2010-04-07 |
Andreas Reichert |
Procédé de traitement de maladies liées à un dysfonctionnement mitochondrial
|
EP2178551A4
(fr)
*
|
2007-07-24 |
2010-07-21 |
Sanare Invest As |
Nouveaux peptides
|
CN101910196A
(zh)
|
2007-12-28 |
2010-12-08 |
诺沃-诺迪斯克有限公司 |
Ddr1-介导的从它们的祖细胞向胰腺内分泌细胞的细胞纯化
|
CA2730710C
(fr)
|
2008-07-24 |
2021-06-08 |
Nsgene A/S |
Utilisation therapeutique d'un facteur de croissance, metrnl
|
ES2638779T3
(es)
|
2009-03-16 |
2017-10-24 |
Pangu Biopharma Limited |
Composiciones y procedimientos que comprenden variantes de splicing de histidil-tarn sintetasa que tienen actividades biológicas no canónicas
|
AR075989A1
(es)
|
2009-04-10 |
2011-05-11 |
Lilly Co Eli |
Anticuerpo dkk -1 (dickkopf-1) humano disenado por ingenieria
|
US8815779B2
(en)
|
2009-09-16 |
2014-08-26 |
SwitchGear Genomics, Inc. |
Transcription biomarkers of biological responses and methods
|
NZ599707A
(en)
|
2009-11-30 |
2014-07-25 |
Genentech Inc |
Antibodies for treating and diagnosing tumors expressing slc34a2 (tat211 = seqid2 )
|
WO2011072265A1
(fr)
|
2009-12-11 |
2011-06-16 |
Atyr Pharma, Inc. |
AMINOACYL-ARNt SYNTHÉTASES DESTINÉES À MODULER UNE INFLAMMATION
|
CA2798301C
(fr)
|
2010-05-04 |
2020-09-15 |
Atyr Pharma, Inc. |
Decouverte innovante de compositions therapeutiques, diagnostiques et a base d'anticorps liees a des fragments proteiques de glutamyl-prolyl-arnt-synthetases
|
KR20180059953A
(ko)
|
2010-07-12 |
2018-06-05 |
에이티와이알 파마, 인코포레이티드 |
히스티딜trna 합성효소의 단백질 단편에 관련된 치료적, 진단적, 및 항체 조성물의 혁신적 발견
|
KR101886029B1
(ko)
|
2010-10-01 |
2018-08-07 |
호바 세라퓨틱스 에이피에스 |
무해자극통증, 통각과민증, 자발통증 및 헛통증의 치료를 위한 메테오린의 용도
|
AU2012284254B2
(en)
|
2011-07-15 |
2015-07-09 |
Oncomed Pharmaceuticals, Inc. |
RSPO binding agents and uses thereof
|
KR102075881B1
(ko)
|
2011-09-05 |
2020-02-11 |
호바 세라퓨틱스 에이피에스 |
이질통, 통각과민증, 자발통 및 환상통의 치료
|
MX356107B
(es)
|
2012-02-16 |
2018-05-15 |
Atyr Pharma Inc |
Histidil-arnt sintetasas para tratar enfermedades autoinmunes e inflamatorias.
|
BR112015000776A2
(pt)
|
2012-07-13 |
2017-08-15 |
Oncomed Pharm Inc |
Agentes de ligação à rspo3 e usos dos mesmos
|
EP2742935A1
(fr)
*
|
2012-12-14 |
2014-06-18 |
Tissue Med Biosciences Forschungs- und Entwicklungsgesellschaft mbH |
SERF2 pour traiter l'atrophie ou augmenter la croissance cellulaire
|
US9587235B2
(en)
|
2013-03-15 |
2017-03-07 |
Atyr Pharma, Inc. |
Histidyl-tRNA synthetase-Fc conjugates
|
EP2878335B1
(fr)
|
2013-11-10 |
2018-01-03 |
Brainsgate Ltd. |
Implant et système d'implantation pour stimulateur neural
|
EP3193935A4
(fr)
|
2014-09-16 |
2018-03-21 |
Oncomed Pharmaceuticals, Inc. |
Traitement de maladies fibrotiques
|
EP3093043B1
(fr)
|
2015-05-13 |
2018-11-14 |
Brainsgate Ltd. |
Implant et système de distribution pour stimulateur neural
|
CN110049769A
(zh)
|
2016-12-04 |
2019-07-23 |
阿拉维·霍拉萨尼·默哈达姆·马塞尔·维克托 |
治疗与线粒体应激相关的疾病的方法
|
US10905766B2
(en)
*
|
2017-03-23 |
2021-02-02 |
Oregon State University |
Therapeutic compositions and methods for treatment of muscle wasting diseases
|
ES2955852T3
(es)
|
2017-04-03 |
2023-12-07 |
Hoffmann La Roche |
Anticuerpos de unión a STEAP-1
|
AU2018256435A1
(en)
|
2017-04-20 |
2019-11-07 |
Atyr Pharma, Inc. |
Compositions and methods for treating lung inflammation
|
CN110910960B
(zh)
*
|
2019-11-30 |
2022-07-08 |
浙江天科高新技术发展有限公司 |
一种鲍曼不动杆菌分子血清型快速分析方法
|
PE20240888A1
(es)
*
|
2020-12-08 |
2024-04-24 |
Imagine Pharma Llc |
Composiciones y metodos para tratar heridas
|